Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00165737
Status:
COMPLETED
Last Update Posted:
2011-04-01
First Post:
2005-09-12
Brief Title:
Donepezil Hydrochloride E2020 in Dementia Associated With Cerebrovascular Disease
Sponsor:
Eisai Inc
Organization:
Eisai Inc
Study Overview
Official Title:
A 24-Week Multi-Center Randomized Double-Blind Placebo-Controlled Evaluation of the Efficacy Safety and Tolerability of Donepezil Hydrochloride E2020 in Patients With Dementia Associated With Cerebrovascular Disease
Status:
COMPLETED
Status Verified Date:
2011-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Twenty-four week prospective randomized double-blind placebo-controlled parallel-group study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None